HIV-1 recombinant gp160 vaccine given in accelerated dose schedules

The purpose of this randomized, double-blind study was to test the safety and immunogenicity of an HIV-1(LAI) recombinant gp160 (rgp160) vaccine in healthy, uninfected volunteers using accelerated dosing schedules. Thirty volunteers were randomly assigned to receive 50-μg doses of rgp160 in one of t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Gorse, G. J., Schwartz, D. H., Graham, B. S., Matthews, T. J., Stablein, D. M., Frey, S. E., Belshe, R. B., Clements, M. L., Wright, P. F., Eibl, M., Fast, P. E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 1994
Konular:
AIDS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1534411/
https://ncbi.nlm.nih.gov/pubmed/7955519
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller